Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03553420Recruiting

Registry for Patients With Lipodystrophy

Role: collaborator

NCT04844164Phase 1Completed

Vitamin D Metabolism in Patients With Endocrine Disorders

Role: lead

NCT04579263Not ApplicableCompleted

Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

Role: collaborator

NCT02574195Completed

Evolution of Effectiveness of Diabetes Medical Care in Russia

Role: lead

NCT02423993Not ApplicableCompleted

Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy

Role: lead

All 5 trials loaded